A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.

Mok, Shaffer R S; Mohan, Sachin; Grewal, Navjot; Elfant, Adam B; Judge, Thomas A

Mok, Shaffer R S; Mohan, Sachin; Grewal, Navjot; Elfant, Adam B; Judge, Thomas A.

Afiliação

Mok SR; Division of Gastroenterology and Liver Diseases, Department of Medicine, Cooper Medical School of Rowan University, MD Anderson Cancer Center at Cooper, Mount Laurel, NJ, USA.
Mohan S; Division of Gastroenterology and Liver Diseases, Department of Medicine, Cooper Medical School of Rowan University, MD Anderson Cancer Center at Cooper, Mount Laurel, NJ, USA.
Grewal N; Division of Gastroenterology and Liver Diseases, Department of Medicine, Cooper Medical School of Rowan University, MD Anderson Cancer Center at Cooper, Mount Laurel, NJ, USA.
Elfant AB; Division of Gastroenterology and Liver Diseases, Department of Medicine, Cooper Medical School of Rowan University, MD Anderson Cancer Center at Cooper, Mount Laurel, NJ, USA.
Judge TA; Division of Gastroenterology and Liver Diseases, Department of Medicine, Cooper Medical School of Rowan University, MD Anderson Cancer Center at Cooper, Mount Laurel, NJ, USA.

J Gastrointest Oncol ; 7(4): 570-9, 2016 Aug.

Article em En | MEDLINE | ID: mdl-27563447

Palavras-chave

Hepatocellular carcinoma (HCC); biomarker; cholangiocarcinoma (CC); genetic; hepatocellular carcinoma-cholangiocarcinoma (HCC-CC)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google